Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men

The American Journal of Medicine

Volumn 83, Issue 2, 1987, Pages 208-212

  Mayer, Kenneth H ^a,b,c   Falk, Lawrence A ^d   Paul, Deborah A ^d   Dawson, George J ^d   Stoddard, Anne M ^e   McCusker, Jane ^e   Saltzman, Scott P ^f   Moon, Martha W ^f   Ferriani, Roberta ^f   Groopman, Jerome E ^f  

^a FENWAY INSTITUTE   (United States)

^b MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^c BROWN UNIVERSITY   (United States)

^d ABBOTT LABORATORIES   (United States)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED COMPLEX; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV; HOMOSEXUALITY; HUMAN; MALE; OPPORTUNISTIC INFECTIONS; RECOMBINANT PROTEINS; SEX BEHAVIOR; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 0023624925     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(87)90686-3     Document Type: Article

References (38)

1. Development and early natural history of HTLV-III antibodies in persons with hemophilia
2. Three year incidence of AIDS among HTLV-III infected risk group members: a comparison of five cohorts
3. The acquired immunodeficiency syndrome in a cohort of homosexual men: a six year follow-up study
4. Follow-up at 41/2 years on homosexual men with generalized lymphadenopathy
5. Risk for HTLV-III exposure and AIDS among parenteral drug abusers in New Jersey
6. The incidence rate of acquired immunodeficiency syndrome in selected populations
7. Transfusion-associated acquired immunodeficiency syndrome: evidence for persistent infection in blood donors
8. The acquired immunodeficiency syndrome in persons with hemophilia
9. The natural history of infection with the lymphadenopathy-associated virus human T-lymphotropic virus type III
10. AIDS: has the problem been adequately assessed?
11. Cofactors in the development of AIDS and AIDS-related conditions
12. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston
13. Association of human T-lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy
14. Natural history of HTLV-III/LAV infection in asymptomatic male homosexuals in Boston
15. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of West Africa
16. Serological characterization of HTLV-III infection in AIDS and related disorders
17. Human T-lymphotropic virus type III in high risk antibody-negative homosexual men
18. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders
19. Potential use of serum assays for HTLV-III Ag and Ab in following disease progression in Ab + individuals
20. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection
21. Antigenemia and antibody titers to core and envelope antigens in AIDS, ARC, and subclinical HIV infection
22. Detection of HTLV-III viral antigens in serum
23. Persistent HIV antigenaemia and decline of HIV core antibodies are associated with transition to AIDS
24. A confirmatory assay for antibodies to HTLV-III
25. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men
26. Serodiagnosis of antibodies to the human AIDS retrovirus with a bacterially synthesized ENV polypeptide
27. Immunopathogenesis of the acquired immunodeficiency syndrome
28. Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome
29. Distinct IgG recognition patterns during progression of subclinical and clinical infection with LAV/HTLV-III
30. Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS)
31. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS
32. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS
33. Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24
34. Bacterial expression of the AIDS retrovirus p24 GAG protein and its use as a diagnostic reagent
35. The clinical laboratory in the diagnosis and management of AIDS and HTLV-III/LAV infections